mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.07 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.07 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.093 |
0.07 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.07 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.08 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.1 |